ADRB2 and Parkinson disease: This suggests that enhancing β2-AR signaling downregulates the neuroinflammatory response after overexpression of hα-SYN which is consistent with previous reports showing β2-AR signaling reducing microglia activation in a neurotoxin-based model of PD [18, 35].